MysteriousPersian

200% gain on positive data?

Short
NASDAQ:AXSM   Axsome Therapeutics, Inc.
Positive data for one drug trial is not nearly enought to justify such a drastic increase in price.
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.